Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Retention and linkage to care news

Show

From To
Confidentiality breaches, stigma and a lack of time are stopping men in Côte d’Ivoire from getting tested and treated for HIV

Interviews with men in Côte d’Ivoire reveal radical differences in the perceptions of those who do and don’t access care. Research, published in PLOS ONE, found many of the worries of men out of care are not reflected in the experiences of those with regular contact with services. Men’s perceptions were linked with their level of engagement with HIV care, with men who have regular contact with HIV testing and treatment services displaying more positive attitudes than those with little or no contact with such services. The paper can be seen at https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0211385

Published
24 April 2019
From
AVERT
Cote d'Ivoire: Privacy concerns keep men from HIV testing, treatment

Privacy concerns linked to both health facilities and providers are major barriers to increasing the number of men who are tested and treated for HIV in Cote d'Ivoire, suggests new Johns Hopkins Center for Communication Programs (CCP) research. CCP is based at the Johns Hopkins Bloomberg School of Public Health.

Published
26 March 2019
From
Eurekalert Medicine & Health
US: 80% of new HIV cases transmitted by undiagnosed or untreated people

In 2016, more than 80% of new HIV infections in the United States were transmitted by individuals who either did not know they were infected with HIV or had been diagnosed but were not receiving care, according to data released on the first day of the National HIV Prevention Conference in Atlanta.

Published
19 March 2019
From
Healio
Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

Strategies abound to end the AIDS epidemic, but expense — mostly for drugs costing up to $50,000 a year — is the inevitable obstacle.

Published
14 March 2019
From
The New York Times
South Africa: The problem of stopping or not starting HIV treatment

South Africa has the largest HIV epidemic in the world. The United Nations Programme on HIV/AIDS (UNAIDS) estimates that there are approximately 7.2-million South Africans living with HIV, with 270 000 new HIV infections in 2017. South Africa also has the largest antiretroviral therapy (ART) programme with more than four million people estimated to be on treatment. Despite progress in getting people onto treatment, recent evidence indicates that the country is still experiencing significant numbers of people developing and dying from advanced HIV-disease. This is as result of people who either do not start treatment, start treatment late, or stop and re-start treatment. There is, therefore, an urgent need to not only prioritise HIV-testing but to ensure that once people start treatment, they remain on life-long care.

Published
12 March 2019
From
Spotlight
India’s first LGBTQ clinic and HIV treatment centre inaugurated in Mumbai

Based out of the Humsafar Trust’s office jn Mumbai, the centre will give free counselling and provide Anti-Retroviral Therapy (ART) to the LGBTQ community. TAshok Row Kavi, founder chairperson of the Trust, said: “Until now we would get testing done for the community members at our centre. If tested positive for the disease, they would be asked to go to Sion Hospital, but there was a huge dropout (rate) there. Because of how the community is perceived outside, a lot of these people wouldn’t seek treatment."

Published
12 March 2019
From
Hindustan Times
Researchers Report High Rate of Viral Suppression Among People New to HIV Care

Eighty-six percent of individuals who entered HIV care soon after diagnosis maintained viral suppression after 48 weeks during a clinical trial conducted at four National Institutes of Health (NIH)-funded Centers for AIDS Research (CFARs) across the United States. Participants in the clinical trial, called iENGAGE, achieved viral suppression in an average of just 63 days. The findings were presented in a poster at the Conference on Retroviruses and Opportunistic Infections (link is external) (CROI 2019) in Seattle.

Published
08 March 2019
From
NIAID
San Francisco Is Beating H.I.V. Why Can’t Houston?

We know how to fight the epidemic, but patients in the South still aren’t getting the treatment they need.

Published
04 March 2019
From
The New York Times
Viral load monitoring motivates HIV treatment adherence in eSwatini

The treat-all policy will only succeed if people keep taking their HIV treatment. It is important to motivate people who started treatment while they were still feeling well. 

Published
24 February 2019
From
AVERT
Viral Load Does Not Equal Value

Are We Shaming Those Who Are Detectable? To contend with this issue and fight the epidemic, we must confront structural barriers and address stigma. What’s more, we must imagine new ways to provide community support beyond offering only clinical solutions.

Published
20 February 2019
From
POZ
← First12345...12Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.